Meet The Team

As President and Founder of the Endometrial Cancer Research Foundation, Corby Arthur brings a deeply personal and extensive background to the role, having been diagnosed with endometrial cancer multiple times since 2015 and actively advocating for uterine cancer patients. Her experience includes managing the SHARE Uterine Cancer Helpline, training volunteers and facilitators for support groups, and creating educational materials, demonstrating a profound commitment to supporting and informing the patient community. Additionally, her previous career as a classroom teacher and Gifted and Talented Coordinator, highlights strong leadership, organizational, and creative thinking skills, all invaluable assets for leading a research foundation dedicated to advancing endometrial cancer understanding and treatment.

Dana Mathews was diagnosed in 2023 with stage 3C2 endometrial carcinosarcoma and a BRCA1 mutation after years of experiencing symptoms that were overlooked or normalized—an all-too-common reality in gynecologic healthcare. Her story underscores the urgent need to address gaps in awareness, delayed diagnoses, and disparities in care that continue to put lives at risk.

As a board member and patient advocate, Dana is committed to advancing education, outreach, and equity in endometrial cancer care. She works to amplify patient voices, strengthen support for survivors, and drive meaningful change through advocacy.

With more than a decade of experience in strategic marketing and nonprofit communications, Dana brings a deep commitment to ECRF. She leverages her skills to lead mission-driven outreach that raises awareness, builds connections, and inspires action.

Naomi is a stage IV endometrial cancer survivor and patient advocate whose work centers on elevating patient voices and improving access to equitable cancer care. Diagnosed at age 27 after a delayed diagnosis, her lived experience informs her advocacy across research, policy, and community engagement spaces.

Naomi has spent the last few years as a Patient Advocate with national organizations, including Patients Rising, American Cancer Society, and Cancer Nation, contributing to patient-centered initiatives focused on access, affordability, and representation.

Naomi currently serves as the Patient Advocacy & Engagement Lead and Board Member at ECRF, where she leads the organization’s patient advocacy program and guides its brand, community engagement strategy, and outreach efforts. She brings over ten years of nonprofit experience supporting fundraising, community engagement, and digital campaigns, and is deeply committed to advancing patient-centered collaboration and meaningful change in cancer care.

At Large

Amy S. Goldman has a long history of service and leadership in statewide and national nonprofits, including co-executive director of the Institute on Disabilities at Temple University, Pennsylvania's University Center of Excellence in Disability, chair of the National Council of State Boards of Examiners in Speech-Language Pathology and Audiology, and currently Past-President of the United States Society for Augmentative and Alternative Communication.  She is also a member of the Board of Directors of Cancer Support Community Greater Philadelphia.  She is a survivor of uterine (endometrial) cancer.

At large

Jeanne T. Pasha brings over three decades of marketing research, business development, and entrepreneurial expertise to her role as a board member. As the Founder and Owner of Worldwide Authentications, she has demonstrated her ability to build successful businesses from the ground up while fostering strong relationships with clients and government agencies. Her extensive background includes serving as Vice President for Marketing Research at Woelfel Research, Inc. for twenty years, where she specialized in data analysis, questionnaire development, and providing strategic insights to drive business decisions.

She is passionate about supporting endometrial cancer research and awareness because it represents one of the fastest-growing cancers, yet remains severely underfunded and under-researched. Jeanne brings her dedication to excellence, strong communication skills, and proven track record of building meaningful partnerships to support the organization's mission of advancing endometrial cancer research and patient advocacy.

Gynecologic Medical Oncologist, Professor 

UCLA Health, University of California, Los Angeles

Dr. Gottfried Konecny is a Gynecologic Medical Oncologist and Professor at UCLA Health. He is also a Scientific Advisor. He translates research into novel treatment approaches for gynecologic cancers, treating patients based on the genetic alterations of their tumors. Dr. Konecny leads gynecologic oncology in the Department of Medicine at UCLA. He received his medical degree and completed his residency in obstetrics and gynecology at the University of Munich, Germany. He conducted postdoctoral studies in Dennis J. Slamon's lab, contributing to the development of breast cancer drugs like trastuzumab and lapatinib. He completed a gynecologic oncology fellowship at Mayo Clinic and was recruited back to UCLA in 2007 to lead a lab for preclinical drug and clinical trial development in gynecologic malignancies.